Johnson & Johnson (JNJ) EPS (Basic) (2009 - 2026)

Johnson & Johnson has disclosed EPS (Basic) across 18 years of filings, most recently posting $2.17 for Q1 2026.

• EPS (Basic) for Q1 2026 came in at $2.17, down 52.52% year-over-year; the trailing twelve-month figure through Mar 2026 was $8.73 (down 3.64% YoY), and the FY2025 annual result was $11.13, up 90.58% from the prior year.
• EPS (Basic) came in at $2.17 for Q1 2026 at Johnson & Johnson, up from $2.12 in the prior quarter.
• In the past five years, EPS (Basic) ranged from a high of $10.32 in Q4 2023 to a low of -$0.03 in Q2 2023.
• The 5-year median for EPS (Basic) is $1.83 (2022), against an average of $2.34.
• Across the five-year window, EPS (Basic) sank 101.72% in 2023 and jumped 4600.0% in 2024, its largest moves.
• Johnson & Johnson's EPS (Basic) stood at $1.7 in 2022, then fell by 1.18% to $1.68 in 2023, then declined by 15.48% to $1.42 in 2024, then jumped by 49.3% to $2.12 in 2025, then gained by 2.36% to $2.17 in 2026.
• The last three EPS (Basic) figures came in at $2.17 (Q1 2026), $2.12 (Q4 2025), and $2.14 (Q3 2025), per Business Quant data.